Form 4 for SPRO Spero Therapeutics, Inc.
Accepted 2024-08-06 00:00:00 ET · period of report 2024-08-02 · accession 0000950170-24-092170 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-08-06 | 2024-08-02+ | SPRO | Shukla Sath | CEO, Pres | S - Sale | $1.31 | -32.4K | 1.14M | -3% | -$42.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-08-02 | S | D | 14,800 | $1.32 | 1,161,207 | D | — | — | |
| 2 | Common | Common Stock | 2024-08-05 | S | D | 17,641 | $1.31 | 1,143,566 | D | — | — |